TY - JOUR AU - Znaor, A. PY - 2015 DA - 2015// TI - International Variations and Trends in Renal Cell Carcinoma Incidence and Mortality JO - Eur Urol VL - 67 UR - https://doi.org/10.1016/j.eururo.2014.10.002 DO - 10.1016/j.eururo.2014.10.002 ID - Znaor2015 ER - TY - STD TI - National Cancer Institute. http://seer.cancer.gov/. Accessed 21 Aug 2015. UR - http://seer.cancer.gov/ ID - ref2 ER - TY - STD TI - World Cancer reports, International Agency for Research on Cancer. http://www.iarc.fr/. Accessed 21 Aug 2015. UR - http://www.iarc.fr/ ID - ref3 ER - TY - STD TI - The World Health Organization. http://www.who.org/. Accessed 21 Aug 2015. UR - http://www.who.org/ ID - ref4 ER - TY - JOUR AU - Linehan, W. M. AU - Srinivasan, R. AU - Schmidt, L. S. PY - 2010 DA - 2010// TI - The genetic basis of kidney cancer: a metabolic disease JO - Nat Rev Urol VL - 7 UR - https://doi.org/10.1038/nrurol.2010.47 DO - 10.1038/nrurol.2010.47 ID - Linehan2010 ER - TY - STD TI - NCBI. http://www.ncbi.nlm.nih.gov/. Accessed 21 Aug 2015. UR - http://www.ncbi.nlm.nih.gov/ ID - ref6 ER - TY - JOUR AU - Leonardi, E. AU - Murgia, A. AU - Tosatto, S. C. PY - 2009 DA - 2009// TI - Adding structural information to the von Hippel-Lindau (VHL) tumor suppressor interaction network JO - FEBS Lett VL - 583 UR - https://doi.org/10.1016/j.febslet.2009.10.070 DO - 10.1016/j.febslet.2009.10.070 ID - Leonardi2009 ER - TY - JOUR AU - Kamura, T. PY - 1999 DA - 1999// TI - Rbx1, a Component of the VHL Tumor Suppressor Complex and SCF Ubiquitin Ligase JO - Science VL - 284 UR - https://doi.org/10.1126/science.284.5414.657 DO - 10.1126/science.284.5414.657 ID - Kamura1999 ER - TY - JOUR AU - Iwai, K. PY - 1999 DA - 1999// TI - Identification of the von Hippel-lindau tumor-suppressor protein as part of an active E3 ubiquitin ligase complex JO - Proc Natl Acad Sci USA VL - 96 UR - https://doi.org/10.1073/pnas.96.22.12436 DO - 10.1073/pnas.96.22.12436 ID - Iwai1999 ER - TY - JOUR AU - Shen, C. AU - Kaelin, W. G. PY - 2013 DA - 2013// TI - The VHL/HIF axis in clear cell renal carcinoma JO - Semin Cancer Biol VL - 23 UR - https://doi.org/10.1016/j.semcancer.2012.06.001 DO - 10.1016/j.semcancer.2012.06.001 ID - Shen2013 ER - TY - JOUR AU - Struckmann, K. PY - 2008 DA - 2008// TI - pVHL co-ordinately regulates CXCR4/CXCL12 and MMP2/MMP9 expression in human clear-cell renal cell carcinoma JO - J Pathol VL - 214 UR - https://doi.org/10.1002/path.2310 DO - 10.1002/path.2310 ID - Struckmann2008 ER - TY - JOUR AU - Frew, I. J. AU - Moch, H. PY - 2015 DA - 2015// TI - A clearer view of the molecular complexity of clear cell renal cell carcinoma JO - Annu Rev Pathol. VL - 10 UR - https://doi.org/10.1146/annurev-pathol-012414-040306 DO - 10.1146/annurev-pathol-012414-040306 ID - Frew2015 ER - TY - JOUR AU - Young, A. C. PY - 2009 DA - 2009// TI - Analysis of VHL Gene Alterations and their Relationship to Clinical Parameters in Sporadic Conventional Renal Cell Carcinoma JO - Clin Cancer Res VL - 15 UR - https://doi.org/10.1158/1078-0432.CCR-09-2131 DO - 10.1158/1078-0432.CCR-09-2131 ID - Young2009 ER - TY - JOUR AU - Gossage, L. AU - Eisen, T. PY - 2010 DA - 2010// TI - Alterations in VHL as potential biomarkers in renal-cell carcinoma JO - Nat Rev Clin Oncol VL - 7 UR - https://doi.org/10.1038/nrclinonc.2010.42 DO - 10.1038/nrclinonc.2010.42 ID - Gossage2010 ER - TY - STD TI - Banks RE, et al. Genetic and epigenetic analysis of von Hippel-Lindau (VHL) gene alterations and relationship with clinical variables in sporadic renal cancer. Cancer Res. 2006;66(4):2000-11. ID - ref15 ER - TY - JOUR AU - Nickerson, M. L. PY - 2008 DA - 2008// TI - Improved identification of von Hippel-Lindau gene alterations in clear cell renal tumors JO - Clin Cancer Res VL - 14 UR - https://doi.org/10.1158/1078-0432.CCR-07-4921 DO - 10.1158/1078-0432.CCR-07-4921 ID - Nickerson2008 ER - TY - JOUR AU - Kondo, K. PY - 2002 DA - 2002// TI - Comprehensive mutational analysis of the VHL gene in sporadic renal cell carcinoma: relationship to clinicopathological parameters JO - Genes Chromosomes Cancer VL - 34 UR - https://doi.org/10.1002/gcc.10054 DO - 10.1002/gcc.10054 ID - Kondo2002 ER - TY - JOUR AU - Cowey, C. L. AU - Rathmell, W. K. PY - 2009 DA - 2009// TI - VHL gene mutations in renal cell carcinoma: Role as a biomarker of disease outcome and drug efficacy JO - Curr Oncol Rep VL - 11 UR - https://doi.org/10.1007/s11912-009-0015-5 DO - 10.1007/s11912-009-0015-5 ID - Cowey2009 ER - TY - JOUR AU - Schraml, P. PY - 2002 DA - 2002// TI - VHL mutations and their correlation with tumour cell proliferation, microvessel density, and patient prognosis in clear cell renal cell carcinoma JO - J Pathol VL - 196 UR - https://doi.org/10.1002/path.1034 DO - 10.1002/path.1034 ID - Schraml2002 ER - TY - JOUR AU - Song, Y. PY - 2015 DA - 2015// TI - Analyses of Potential Predictive Markers and Response to Targeted Therapy in Patients with Advanced Clear-cell Renal Cell Carcinoma JO - Chin Med J (Engl) VL - 128 UR - https://doi.org/10.4103/0366-6999.161353 DO - 10.4103/0366-6999.161353 ID - Song2015 ER - TY - JOUR AU - Gad, S. PY - 2006 DA - 2006// TI - Somatic von Hippel-Lindau (VHL) gene analysis and clinical outcome under antiangiogenic treatment in metastatic renal cell carcinoma: preliminary results JO - Target Oncol VL - 2 UR - https://doi.org/10.1007/s11523-006-0039-9 DO - 10.1007/s11523-006-0039-9 ID - Gad2006 ER - TY - STD TI - Choueiri TK, et al. von Hippel-Lindau gene status and response to vascular endothelial growth factor targeted therapy for metastatic clear cell renal cell carcinoma. J Urol. 2008;180(3):860-5. discussion 865-6. ID - ref22 ER - TY - JOUR AU - Rechsteiner, M. P. PY - 2011 DA - 2011// TI - VHL gene mutations and their effects on hypoxia inducible factor HIFalpha: identification of potential driver and passenger mutations JO - Cancer Res VL - 71 UR - https://doi.org/10.1158/0008-5472.CAN-11-0757 DO - 10.1158/0008-5472.CAN-11-0757 ID - Rechsteiner2011 ER - TY - JOUR AU - Li, Z. PY - 2002 DA - 2002// TI - Ubiquitination of a Novel Deubiquitinating Enzyme Requires Direct Binding to von Hippel-Lindau Tumor Suppressor Protein JO - J Biol Chem VL - 277 UR - https://doi.org/10.1074/jbc.M108269200 DO - 10.1074/jbc.M108269200 ID - Li2002 ER - TY - JOUR AU - Feldman, D. E. PY - 2003 DA - 2003// TI - Tumorigenic Mutations in VHL Disrupt Folding In Vivo by Interfering with Chaperonin Binding JO - Mol Cell VL - 12 UR - https://doi.org/10.1016/S1097-2765(03)00423-4 DO - 10.1016/S1097-2765(03)00423-4 ID - Feldman2003 ER - TY - JOUR AU - Khacho, M. PY - 2008 DA - 2008// TI - eEF1A Is a Novel Component of the Mammalian Nuclear Protein Export Machinery JO - Mol Biol Cell VL - 19 UR - https://doi.org/10.1091/mbc.E08-06-0562 DO - 10.1091/mbc.E08-06-0562 ID - Khacho2008 ER - TY - JOUR AU - Hoffman, M. A. PY - 2001 DA - 2001// TI - von Hippel-Lindau protein mutants linked to type 2C VHL disease preserve the ability to downregulate HIF JO - Hum Mol Genet VL - 10 UR - https://doi.org/10.1093/hmg/10.10.1019 DO - 10.1093/hmg/10.10.1019 ID - Hoffman2001 ER - TY - JOUR AU - Zhou, M. I. PY - 2004 DA - 2004// TI - Tumor Suppressor von Hippel-Lindau (VHL) Stabilization of Jade-1 Protein Occurs through Plant Homeodomains and Is VHL Mutation Dependent JO - Cancer Res VL - 64 UR - https://doi.org/10.1158/0008-5472.CAN-03-0884 DO - 10.1158/0008-5472.CAN-03-0884 ID - Zhou2004 ER - TY - STD TI - Yi Y, et al. von Hippel-Lindau–Dependent Patterns of RNA Polymerase II Hydroxylation in Human Renal Clear Cell Carcinomas. Clin Cancer Res. 2010;16(21):5142–152. ID - ref29 ER - TY - JOUR AU - Lai, Y. PY - 2012 DA - 2012// TI - The interaction of the von Hippel-Lindau tumor suppressor and heterochromatin protein 1 JO - Arch Biochem Biophys VL - 518 UR - https://doi.org/10.1016/j.abb.2011.12.023 DO - 10.1016/j.abb.2011.12.023 ID - Lai2012 ER - TY - JOUR AU - Yang, C. PY - 2013 DA - 2013// TI - Proteostasis modulators prolong missense VHL protein activity and halt tumor progression JO - Cell Rep VL - 3 UR - https://doi.org/10.1016/j.celrep.2012.12.007 DO - 10.1016/j.celrep.2012.12.007 ID - Yang2013 ER - TY - JOUR AU - Teichman, A. PY - 2012 DA - 2012// TI - Whole genome and transcriptome amplification: practicable tools for sustainable tissue biobanking? JO - Virchows Arch VL - 461 UR - https://doi.org/10.1007/s00428-012-1315-y DO - 10.1007/s00428-012-1315-y ID - Teichman2012 ER - TY - JOUR AU - Taylor, C. PY - 2012 DA - 2012// TI - Determination of the consequences of VHL mutations on VHL transcripts in renal cell carcinoma JO - Int J Oncol VL - 41 ID - Taylor2012 ER - TY - JOUR AU - Schraml, P. PY - 2003 DA - 2003// TI - Relevance of nuclear and cytoplasmic von hippel lindau protein expression for renal carcinoma progression JO - Am J Pathol VL - 163 UR - https://doi.org/10.1016/S0002-9440(10)63461-X DO - 10.1016/S0002-9440(10)63461-X ID - Schraml2003 ER - TY - JOUR AU - Alves, M. PY - 2014 DA - 2014// TI - Mutational status of VHL gene and its clinical importance in renal clear cell carcinoma JO - Virchows Archiv VL - 465 UR - https://doi.org/10.1007/s00428-014-1629-z DO - 10.1007/s00428-014-1629-z ID - Alves2014 ER - TY - JOUR AU - Eisenhauer, E. A. PY - 2009 DA - 2009// TI - New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1) JO - Eur J Cancer VL - 45 UR - https://doi.org/10.1016/j.ejca.2008.10.026 DO - 10.1016/j.ejca.2008.10.026 ID - Eisenhauer2009 ER - TY - STD TI - Sequencher® version 5.3 sequence analysis software, Gene Codes Corporation, Ann Arbor, MI USA, http://www.genecodes.com. UR - http://www.genecodes.com ID - ref37 ER - TY - STD TI - Site Directed Mutator, http://mordred.bioc.cam.ac.uk/~sdm/links.php. Accessed 27 July 2015. UR - http://mordred.bioc.cam.ac.uk/~sdm/links.php ID - ref38 ER - TY - JOUR AU - Gossage, L. AU - Eisen, T. AU - Maher, E. R. PY - 2015 DA - 2015// TI - VHL, the story of a tumour suppressor gene JO - Nat Rev Cancer VL - 15 UR - https://doi.org/10.1038/nrc3844 DO - 10.1038/nrc3844 ID - Gossage2015 ER - TY - STD TI - Gerstung M, et al. Reliable detection of subclonal single-nucleotide variants in tumour cell populations. Nat Commun. 2012;3:811. ID - ref40 ER - TY - JOUR AU - Moch, H. PY - 1998 DA - 1998// TI - Intratumoral Heterogeneity of Von Hippel-Lindau Gene Deletions in Renal Cell Carcinoma Detected by Fluorescence in Situ Hybridization JO - Cancer Res VL - 58 ID - Moch1998 ER - TY - STD TI - Gerlinger M, et al. Genomic architecture and evolution of clear cell renal cell carcinomas defined by multiregion sequencing. Nat Genet. 2014;46(3). ID - ref42 ER - TY - JOUR AU - Gallou, C. PY - 1999 DA - 1999// TI - Mutations of the VHL gene in sporadic renal cell carcinoma: Definition of a risk factor for VHL patients to develop an RCC JO - Hum Mutat VL - 13 UR - https://doi.org/3.0.CO;2-A DO - 3.0.CO;2-A ID - Gallou1999 ER - TY - STD TI - VHL mutations database-UMD, http://www.umd.be/VHL/. Accessed 29 Sept 2015. UR - http://www.umd.be/VHL/ ID - ref44 ER - TY - STD TI - COSMIC database, http://cancer.sanger.ac.uk/cosmic. Accessed 29 Sept 2015. UR - http://cancer.sanger.ac.uk/cosmic ID - ref45 ER - TY - JOUR AU - Simone, M. C. AU - Rathmell, W. K. AU - Threadgill, D. W. PY - 2013 DA - 2013// TI - Pleiotropic Effects of the Trichloroethylene-Associated P81S VHL Mutation on Metabolism, Apoptosis, and ATM-Mediated DNA Damage Response JO - J Natl Cancer Inst VL - 105 UR - https://doi.org/10.1093/jnci/djt226 DO - 10.1093/jnci/djt226 ID - Simone2013 ER - TY - JOUR AU - Kanno, T. PY - 2012 DA - 2012// TI - JunB promotes cell invasion and angiogenesis in VHL-defective renal cell carcinoma JO - Oncogene VL - 31 UR - https://doi.org/10.1038/onc.2011.475 DO - 10.1038/onc.2011.475 ID - Kanno2012 ER - TY - JOUR AU - Lee, S. PY - 2005 DA - 2005// TI - Neuronal apoptosis linked to EglN3 prolyl hydroxylase and familial pheochromocytoma genes: Developmental culling and cancer JO - Cancer Cell VL - 8 UR - https://doi.org/10.1016/j.ccr.2005.06.015 DO - 10.1016/j.ccr.2005.06.015 ID - Lee2005 ER - TY - JOUR AU - Feldman, D. E. PY - 1999 DA - 1999// TI - Formation of the VHL–Elongin BC Tumor Suppressor Complex Is Mediated by the Chaperonin TRiC JO - Mol Cell VL - 4 UR - https://doi.org/10.1016/S1097-2765(00)80233-6 DO - 10.1016/S1097-2765(00)80233-6 ID - Feldman1999 ER - TY - JOUR AU - Tsuchiya, H. AU - Iseda, T. AU - Hino, O. PY - 1996 DA - 1996// TI - Identification of a Novel Protein (VBP-1) Binding to the von Hippel-Lindau (VHL) Tumor Suppressor Gene Product JO - Cancer Res VL - 56 ID - Tsuchiya1996 ER - TY - JOUR AU - Gossage, L. PY - 2014 DA - 2014// TI - An integrated computational approach can classify VHL missense mutations according to risk of clear cell renal carcinoma JO - Hum Mol Genet VL - 23 UR - https://doi.org/10.1093/hmg/ddu321 DO - 10.1093/hmg/ddu321 ID - Gossage2014 ER - TY - JOUR AU - Kaelin, W. G. PY - 2004 DA - 2004// TI - The von Hippel-Lindau tumor suppressor gene and kidney cancer JO - Clin Cancer Res VL - 10 UR - https://doi.org/10.1158/1078-0432.CCR-sup-040025 DO - 10.1158/1078-0432.CCR-sup-040025 ID - Kaelin2004 ER - TY - JOUR AU - Brugarolas, J. PY - 2014 DA - 2014// TI - Molecular genetics of clear-cell renal cell carcinoma JO - J Clin Oncol VL - 32 UR - https://doi.org/10.1200/JCO.2012.45.2003 DO - 10.1200/JCO.2012.45.2003 ID - Brugarolas2014 ER - TY - BOOK AU - Moch, H. AU - Humphrey, P. A. AU - Ulbright, T. M. AU - Reuter, V. E. PY - 2016 DA - 2016// TI - WHO Classification of Tumours of the Urinary System and Male Genital Organs ID - Moch2016 ER - TY - STD TI - Moch H, Cubilla AL, Humphrey PA, Reuter VE, Ulbright TM. The 2016 WHO classification of tumours of the urinary system and male genital organs. Part A: Renal, penile and testicular tumours. Eur Urol. In press. ID - ref55 ER - TY - JOUR AU - Beuselinck, B. PY - 2015 DA - 2015// TI - Molecular subtypes of clear cell renal cell carcinoma are associated to sunitinib response in the metastatic setting JO - Clin Cancer Res VL - 21 UR - https://doi.org/10.1158/1078-0432.CCR-14-1128 DO - 10.1158/1078-0432.CCR-14-1128 ID - Beuselinck2015 ER - TY - JOUR AU - Brugarolas, J. PY - 2013 DA - 2013// TI - PBRM1 and BAP1 as novel targets for renal cell carcinoma JO - Cancer J VL - 19 UR - https://doi.org/10.1097/PPO.0b013e3182a102d1 DO - 10.1097/PPO.0b013e3182a102d1 ID - Brugarolas2013 ER - TY - STD TI - Cancer Genome Atlas Research, N., Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature. 2013;499(7456):43–9. ID - ref58 ER - TY - STD TI - Gossage L, et al. Clinical and pathological impact of VHL, PBRM1, BAP1, SETD2, KDM6A, and JARID1c in clear cell renal cell carcinoma. Genes Chromosomes Cancer. 2014;53(1):38-51. ID - ref59 ER - TY - STD TI - Hakimi AA, et al. Adverse outcomes in clear cell renal cell carcinoma with mutations of 3p21 epigenetic regulators BAP1 and SETD2: a report by MSKCC and the KIRC TCGA research network. Clin Cancer Res. 2013;19(12):3259-67. ID - ref60 ER - TY - STD TI - Ibragimova I, et al. Aberrant promoter hypermethylation of PBRM1, BAP1, SETD2, KDM6A and other chromatin-modifying genes is absent or rare in clear cell RCC. Epigenetics. 2013;8(5):486-93. ID - ref61 ER - TY - STD TI - Kapur P, et al. Effects on survival of BAP1 and PBRM1 mutations in sporadic clear-cell renal-cell carcinoma: a retrospective analysis with independent validation. Lancet Oncol. 2013;14(2):159-67. ID - ref62 ER - TY - JOUR AU - Liao, L. AU - Testa, J. R. AU - Yang, H. PY - 2015 DA - 2015// TI - The roles of chromatin-remodelers and epigenetic modifiers in kidney cancer JO - Cancer Genet VL - 208 UR - https://doi.org/10.1016/j.cancergen.2015.02.008 DO - 10.1016/j.cancergen.2015.02.008 ID - Liao2015 ER - TY - JOUR AU - Piva, F. PY - 2015 DA - 2015// TI - BAP1, PBRM1 and SETD2 in clear-cell renal cell carcinoma: molecular diagnostics and possible targets for personalized therapies JO - Expert Rev Mol Diagn VL - 15 UR - https://doi.org/10.1586/14737159.2015.1068122 DO - 10.1586/14737159.2015.1068122 ID - Piva2015 ER -